Date: August 14, 2026

Board Meeting Outcomes

The Nomination and Remuneration Committee of the Company passed a circular resolution on August 14, 2026, approving the allotment of 3,49,656 Equity Shares of face value of ₹10/- each to eligible employees pursuant to exercise of options under ESOP - 2021 of the Company.

ESOP Allotment Details

Total Shares Allotted: 3,49,656 equity shares

Exercise Price Breakdown:

  • 1,68,974 options exercised at ₹42 per share (₹10 face value + ₹32 premium)
  • 1,55,894 options exercised at ₹51 per share (₹10 face value + ₹41 premium)
  • 13,156 options exercised at ₹56 per share (₹10 face value + ₹46 premium)
  • 11,632 options exercised at ₹64 per share (₹10 face value + ₹54 premium)

Capital Structure Change:

  • Pre-allotment: 10,38,17,0594 equity shares aggregating to ₹10,38,17,05,940/-
  • Post-allotment: 10,38,52,0250 equity shares aggregating to ₹10,38,52,02,500/-

Share Details:

  • Par value: ₹10 per share
  • Date of issue: August 14, 2026
  • Distinctive numbers: 1,03,81,70,595 to 1,03,85,20,250
  • The new shares rank pari-passu with existing equity shares
  • No lock-in period applicable

Regulatory Compliance:

  • Filed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • ESOP scheme received in-principal approval for 36,00,000 Equity Shares on June 13th, 2023 from both BSE and NSE
  • Filing numbers: BSE: 176099, NSE: 35572

KMP / Board / Auditor Changes

Not Specified

Dividend Declaration or Non-Declaration

Not Specified

Financial Results

Not Specified

Disinvestment / Strategic Actions

Not Specified

Other Operational / Legal / Strategic Disclosures

Not Specified